Menarini Biotech
Flavio Pruni is an experienced professional in the field of pharmaceutical research and development, currently serving as an Analista in Ricerca e Sviluppo at Menarini Biotech since March 2021. Responsibilities include GMP training, in-process controls for production support, and various analytical techniques to determine monoclonal antibody concentration, purity, and identity using methods such as HPLC and Size Exclusion Chromatography. Previous roles include R&D QC Chemical Analyst at MENARINI Group, Analista in Ricerca e Sviluppo at Menarini Biotech, junior consultant at PQE Group focusing on computer system validation, and a research intern at Menarini Biotech. Flavio's academic background includes a master's degree in Pharmacy and Industrial Pharmacy from Sapienza Università di Roma.
Menarini Biotech
4 followers
Menarini Biotech (“MBH”) is a fast-growing, agile, fully integrated CDMO for biologics located in the greater Rome area, Italy. Established in 2003, Menarini Biotech’s mission is to provide fast and efficient, yet very customer-centric, world-class, high-quality, services for biotech companies from preclinical development to GMP manufacturing (Mammalian and Microbial) up to BSL-2. These include CHO cell line development and analytical development for standard and non-standard mAbs, and new molecular formats, e.g. bispecifics, ADCs, fusion proteins. Our Quality System complies with AIFA/EU GMP requirements.